Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1. (Q39463246)
Jump to navigation
Jump to search
scientific article published on 23 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1. |
scientific article published on 23 August 2016 |
Statements
1 reference
Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1. (English)
1 reference
Marisa Dolled-Filhart
1 reference
Charlotte Roach
1 reference
Grant Toland
1 reference
Dave Stanforth
1 reference
Malinka Jansson
1 reference
Gregory M Lubiniecki
1 reference
Gary Ponto
1 reference
Kenneth Emancipator
1 reference
23 August 2016
1 reference
1 reference
Identifiers
1 reference